{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-303045","form_type":"8-K","ticker":"INKT","cik":"0001840229","company_name":"MiNK Therapeutics, Inc.","filed_at":"2021-10-20T23:59:59+00:00","discovered_at":"2026-05-14T18:04:14.623577+00:00","generated_at":"2026-06-28T19:44:09.837356+00:00","sec_items":["3.03","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"MiNK Therapeutics files amended charter post-IPO, authorizing 150M common and 5M preferred shares","bullets":["Amended charter and bylaws became effective upon IPO closing on October 19, 2021.","Authorized capital: 150,000,000 shares of common stock, par value $0.00001 per share.","Authorized capital includes 5,000,000 shares of preferred stock.","Charter and bylaws are in the form previously filed with the Registration Statement on Form S-1.","No other material modifications to security holder rights were reported."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-303045","json":"https://secwatch.observer/filing/0001193125-21-303045.json","markdown":"https://secwatch.observer/filing/0001193125-21-303045.md","text":"https://secwatch.observer/filing/0001193125-21-303045.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1840229/000119312521303045/0001193125-21-303045-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1840229/000119312521303045/d134002d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T19:44:09.837356+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}